ID: ALA609730

Max Phase: Preclinical

Molecular Formula: C14H19NO5

Molecular Weight: 281.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCOc1ccc(C(=O)O)cc1[N+](=O)[O-]

Standard InChI:  InChI=1S/C14H19NO5/c1-2-3-4-5-6-9-20-13-8-7-11(14(16)17)10-12(13)15(18)19/h7-8,10H,2-6,9H2,1H3,(H,16,17)

Standard InChI Key:  VARRQJYVGSIUHU-UHFFFAOYSA-N

Associated Targets(non-human)

lpxC UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 281.31Molecular Weight (Monoisotopic): 281.1263AlogP: 3.64#Rotatable Bonds: 9
Polar Surface Area: 89.67Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.81CX Basic pKa: CX LogP: 4.07CX LogD: 0.81
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.42Np Likeness Score: -0.74

References

1. Shin H, Gennadios HA, Whittington DA, Christianson DW..  (2007)  Amphipathic benzoic acid derivatives: synthesis and binding in the hydrophobic tunnel of the zinc deacetylase LpxC.,  15  (7): [PMID:17296300] [10.1016/j.bmc.2007.01.044]

Source